SpaceX Strikes Deal With Cursor for $60 Billion The potential acquisition comes as Elon Musk’s rocket and satellite maker, which has been emphasizing artificial intelligence, is preparing to go public.

Elon Musk’s SpaceX struck a deal with Cursor, an A.I. start-up, that could lead it to buy the company for $60 billion. nyti.ms/4u1Hqsz

Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure Gilead Sciences and Arcus Biosciences’ domvanalimab, one of the last anti-TIGIT antibodies still standing, has failed another trial—leading Gilead to pull further away from their once wide-ranging | G...

Gilead loosens ties to Arcus after TIGIT dream finally ends up in phase 3 failure | #biotech

Creating medicine is as complex as a moonshot.

bit.ly/4sgzvat

Pipeline is your Mission Control for:
🔹 Target selection
🔹 Library design
🔹 Project planning
🔹 Assay Management
🔹 CRO/CDMO collab

pipeline@aspen.bio

#Biotech #DrugDiscovery

via: Web

03:23 pm, Feb 20, 2026

The Digital Transformation Roadmap - Improving Capital Efficiency & Velocity in Drug Discovery A Digital Transformation Roadmap can show you how to apply technologies like AI, automation and advanced analytics to improve the efficiency and velocity of your drug discovery operations. In this video, we take a look at some of the ways that these technologies can be applied to transform the way new medicines are discovered, and how a roadmap can help provide you with a plan for getting there. #digitaltransformation #drugdiscovery #ai #automation #analytics

Give us 10 minutes and we'll show you how Digital Transformation with AI and Automation can change your drug discovery operations.

bit.ly/4blEtN6

#DrugDiscovery #DigitalTransformation #AI #automation.

Absolutely incredible.

NASA Astronaut Reid Wiseman, who commanded Artemis II, took this footage from the far side of the Moon with his iPhone.

Watch with sound on.

mRNA vaccines continue to show major promise.

In a small Phase 1 trial led by Dr. Balachandran, some patients with pancreatic cancer (one of the deadliest cancers) reached 6-year survival.

This is why sustained investment in science & research matters.

tinyurl.com/f4n4anhk

Doctors are noticing a concerning trait in babies just hours after birth New research shows that a trait showing up in newborns is bringing concern for their health, all thanks to their gut microbiome.

Doctors are noticing a concerning trait in babies just hours after birth

A Newly Discovered Recording Lets You Hear Delta Blues Legend Robert Johnson in Stunning Clarity Great swathes of rock music since the nineteen-sixties would never have existed, we're sometimes told, were it not for the recordings of Robert Johnson. Certainly the likes of Keith Richards, Eric Cla...

A Newly Discovered Recording Lets You Hear Delta Blues Legend Robert Johnson in Stunning Clarity

Experimental drug doubles one-year survival in pancreatic cancer A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.

Experimental drug doubles one-year survival in pancreatic cancer | Live Science #PDAC #PancreaticCancer #cancer share.google/NHr1SKICLd0d...

Pancreatic cancer mRNA vaccine shows lasting results in an early trial Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.

Pancreatic #cancer mRNA vaccine shows lasting results in an early trial | @biontech.bsky.social @genentech.bsky.social #PDAC #PancreaticCancer #vaccine

OpenAI starts offering a biology-tuned LLM GPT-Rosalind is an LLM trained on biology workflows, available in closed access.

OpenAI starts offering a biology-tuned LLM | #AI #biology #DrugDiscovery

A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment "I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.

A pancreatic cancer expert on why Revolution Medicines' study could 'open up a new era' of treatment | #cancer #PancreaticCancer

Creating medicine is as complex as a moonshot.

bit.ly/4sgzvat

Pipeline is your Mission Control for:
🔹 Target selection
🔹 Library design
🔹 Project planning
🔹 Assay Management
🔹 CRO/CDMO collab

pipeline@aspen.bio

#Biotech #DrugDiscovery

via: Web

03:23 pm, Feb 20, 2026

Kura kidney cancer combo shrank tumors in 75% after cabozantinib Disease control reached 94% in 16 heavily pretreated patients, a group that typically sees limited benefit after cabozantinib. Treatment lasted up to 56 weeks.

Kura kidney cancer combo shrank rumours in 75% after cabozantinib | #cancer

Is your #DrugDiscovery built on science or AI robot monkeys? 🐒🤖
You need a roadmap that reduces risk and increases velocity.

Watch: bit.ly/4rohQgC
Guide: bit.ly/4rOyVRj

#Biotech #Strategy

CRISPR Variant Precisely Targets Tumor DNA for Cancer Therapy In a pioneering breakthrough that could revolutionize cancer therapy, researchers from Wageningen University & Research and Van Andel Institute have unveiled a novel gene-editing approach that

CRISPR variant precisely targets tumor DNA for #cancer therapy

The Digital Transformation Roadmap - Improving Capital Efficiency & Velocity in Drug Discovery A Digital Transformation Roadmap can show you how to apply technologies like AI, automation and advanced analytics to improve the efficiency and velocity of your drug discovery operations. In this video, we take a look at some of the ways that these technologies can be applied to transform the way new medicines are discovered, and how a roadmap can help provide you with a plan for getting there. #digitaltransformation #drugdiscovery #ai #automation #analytics

Give us 10 minutes and we'll show you how Digital Transformation with AI and Automation can change your drug discovery operations.

bit.ly/4blEtN6

#DrugDiscovery #DigitalTransformation #AI #automation.

Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature Identification of genetic variants associated with the efficacy and side effects of GLP1 medications could underpin development of precision medicine approaches in the treatment of obesity.

Genetic predictors of GLP1 receptor agonist weight loss and side effects

Eli Lilly to acquire tiny Houston startup CrossBridge Bio for up to $300M Eli Lilly has agreed to acquire ADC maker CrossBridge Bio for up to $300 million.

Eli Lilly is acquiring CrossBridge Bio for up to $300M, picking up the Houston startup's ADC linker technology just two years after its founding.

Revolution’s much-hyped RAS inhibitor hits key survival goals in phase 3 pancreatic cancer trial Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 stud | ...

Revolution's much height RAS inhibitor hits key survival goals in phase 3 pancreatic cancer trial | #PancreaticCancer #cancer

For Ben Sasse, Revolution Medicines’ pancreatic cancer trial felt like his best, only option Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic cancer.

For Ben Sasse, Revolution Medicines' pancreatic cancer trial felt like his best, only option | #PancreaticCancer #cancer

Looking for a better way of managing your drug discovery portfolio? The Ring of Fire is a new framework that combines data from biology, chemistry, clinical and commercial into a quantitative view of the project.

bit.ly/4s9rjZw

#DrugDiscovery #PPM #PM #PortfolioManagement

Its new cancer drug makes cells self-destruct. Investors bet another $100M on this San Diego startup Since its founding in 2020, Neomorph has inked nearly $5 billion worth of deals with pharmaceutical companies.

It's new #cancer drug makes cells self-destruct. Investors bet another $100M on this San Diego startup | #biotech

New Image of Earth and Moon

This protein helps cancer cells survive treatment—and points to new treatments Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The study provides a deeper understanding of how key proteins interact within the...

This protein helps #cancer cells survive treatment -- and points to new treatments

After layoffs, biotech exits 2 Boston-area leases After layoffs, biotech exits two Boston-area leases

After late, #biotech exits 2 Boston-area leases

San Diego biotech lays off half its workers after failing key drug trial The question remains whether Gossamer has the money and manpower to continue with the costly trials.

San Diego #biotech lays off half its workers after failing key drug trial

Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.

Revolution Medicines touts 'unprecedented' data for pancreatic cancer pill | #PancreaticCancer #cancer

The 2025 AI State of Play is here. 🧬 AI-native drugs are hitting 80-90% Phase I success rates, fundamentally challenging Eroom's Law. This short video explainer fills in the details.

bit.ly/4bvqjId

#AI #DrugDiscovery

Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals. | With its latest obesity play appearing to pay off, Regeneron has turned its attention t...

Regeneron rides into radiopharma via $2.1B biobucks pact with Australia's Telix | #biotech